These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11456364)

  • 1. Mechanisms of antifungal agent resistance.
    Yang YL; Lo HJ
    J Microbiol Immunol Infect; 2001 Jun; 34(2):79-86. PubMed ID: 11456364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cellular and molecular defense mechanisms of the Candida yeasts against azole antifungal drugs.
    Noël T
    J Mycol Med; 2012 Jun; 22(2):173-8. PubMed ID: 23518020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to antifungal therapies.
    Prasad R; Banerjee A; Shah AH
    Essays Biochem; 2017 Feb; 61(1):157-166. PubMed ID: 28258238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
    Walsh TJ; Kasai M; Francesconi A; Landsman D; Chanock SJ
    J Med Vet Mycol; 1997; 35(2):133-7. PubMed ID: 9147273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility.
    Niimi K; Maki K; Ikeda F; Holmes AR; Lamping E; Niimi M; Monk BC; Cannon RD
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1148-55. PubMed ID: 16569823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voriconazole and multidrug resistance in Candida albicans.
    Wakieć R; Prasad R; Morschhäuser J; Barchiesi F; Borowski E; Milewski S
    Mycoses; 2007 Mar; 50(2):109-15. PubMed ID: 17305773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Learning the ABC of oral fungal drug resistance.
    Cannon RD; Holmes AR
    Mol Oral Microbiol; 2015 Dec; 30(6):425-37. PubMed ID: 26042641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal resistance mechanisms in dermatophytes.
    Martinez-Rossi NM; Peres NT; Rossi A
    Mycopathologia; 2008; 166(5-6):369-83. PubMed ID: 18478356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane transporters in self resistance of Cercospora nicotianae to the photoactivated toxin cercosporin.
    Beseli A; Amnuaykanjanasin A; Herrero S; Thomas E; Daub ME
    Curr Genet; 2015 Nov; 61(4):601-20. PubMed ID: 25862648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of ATP-binding cassette and/or major facilitator superfamily class efflux pumps contributes to voriconazole resistance in Aspergillus flavus.
    Natesan SK; Lamichchane AK; Swaminathan S; Wu W
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):458-63. PubMed ID: 23886435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms underlying the tetrandrine-mediated reversal of the fluconazole resistance of Candida albicans.
    Zhang X; Guo H; Gao L; Song Y; Li S; Zhang H
    Pharm Biol; 2013 Jun; 51(6):749-52. PubMed ID: 23527892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational Analysis of Intracellular Loops Identify Cross Talk with Nucleotide Binding Domains of Yeast ABC Transporter Cdr1p.
    Shah AH; Rawal MK; Dhamgaye S; Komath SS; Saxena AK; Prasad R
    Sci Rep; 2015 Jun; 5():11211. PubMed ID: 26053667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [What's new in the molecular basis of antifungal drug resistance in pathogenic yeasts].
    Tanabe K; Niimi K; Niimi M
    Nihon Rinsho; 2008 Dec; 66(12):2273-8. PubMed ID: 19069091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial peptides enhance the candidacidal activity of antifungal drugs by promoting the efflux of ATP from Candida cells.
    Tanida T; Okamoto T; Ueta E; Yamamoto T; Osaki T
    J Antimicrob Chemother; 2006 Jan; 57(1):94-103. PubMed ID: 16291868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yeast ATP-binding cassette transporters conferring multidrug resistance.
    Prasad R; Goffeau A
    Annu Rev Microbiol; 2012; 66():39-63. PubMed ID: 22703054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a yeast-based membrane protein expression technology to overexpress drug resistance efflux pumps.
    Lamping E; Cannon RD
    Methods Mol Biol; 2010; 666():219-50. PubMed ID: 20717788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenicity and drug resistance in Candida albicans and other yeast species. A review.
    Mishra NN; Prasad T; Sharma N; Payasi A; Prasad R; Gupta DK; Singh R
    Acta Microbiol Immunol Hung; 2007 Sep; 54(3):201-35. PubMed ID: 17896473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans.
    Coste A; Turner V; Ischer F; Morschhäuser J; Forche A; Selmecki A; Berman J; Bille J; Sanglard D
    Genetics; 2006 Apr; 172(4):2139-56. PubMed ID: 16452151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cetylpyridinium chloride resistance and treatment on fluconazole activity versus Candida albicans.
    Edlind MP; Smith WL; Edlind TD
    Antimicrob Agents Chemother; 2005 Feb; 49(2):843-5. PubMed ID: 15673785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced azole susceptibility in genotype 3 Candida dubliniensis isolates associated with increased CdCDR1 and CdCDR2 expression.
    Pinjon E; Jackson CJ; Kelly SL; Sanglard D; Moran G; Coleman DC; Sullivan DJ
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1312-8. PubMed ID: 15793103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.